• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of hepatocellular carcinoma in the waiting list before liver transplantation.

作者信息

Majno Pietro, Giostra Emiliano, Morel Philippe, Hadengue Antoine, Mentha Gilles

机构信息

Clinics of Visceral Surgery and Transplantation, University Hospitals of Geneva, 1211 Geneva 14, Switzerland.

出版信息

J Hepatol. 2005;42 Suppl(1):S134-43. doi: 10.1016/j.jhep.2004.12.010.

DOI:10.1016/j.jhep.2004.12.010
PMID:15858867
Abstract
摘要

相似文献

1
Management of hepatocellular carcinoma in the waiting list before liver transplantation.
J Hepatol. 2005;42 Suppl(1):S134-43. doi: 10.1016/j.jhep.2004.12.010.
2
Waiting list treatment of hepatocellular carcinoma: when do we need level 1 evidence?肝细胞癌的等待名单治疗：我们何时需要一级证据？
Am J Transplant. 2006 Nov;6(11):2531-2. doi: 10.1111/j.1600-6143.2006.01572.x.
3
Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.等待肝移植期间肝细胞癌的进展
Transplantation. 2015 Sep;99(9):e155-6. doi: 10.1097/TP.0000000000000826.
4
Is the treatment of hepatocellular carcinoma on the waiting list necessary?等待名单上的肝细胞癌患者是否需要治疗？
Liver Transpl. 2011 Oct;17 Suppl 2:S98-108. doi: 10.1002/lt.22391.
5
Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal.肝移植前肝细胞癌的新辅助治疗：批判性评估
Liver Transpl. 2006 Dec;12(12):1747-54. doi: 10.1002/lt.21018.
6
Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?肝细胞癌降期后患者是否符合肝移植条件？
Liver Transpl. 2011 Oct;17 Suppl 2:S109-16. doi: 10.1002/lt.22335.
7
Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?肝移植等候名单上肝细胞癌的管理：开展对照试验的时候到了吗？
Liver Transpl. 2007 Nov;13(11 Suppl 2):S27-35. doi: 10.1002/lt.21328.
8
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.肝细胞癌患者在等待肝移植期间先进行化疗栓塞可延缓肿瘤进展，并带来良好的预后。
Liver Transpl. 2003 Jun;9(6):557-63. doi: 10.1053/jlts.2003.50106.
9
Treatment of hepatocellular carcinoma: pathologic results after chemoembolization and liver transplantation.肝细胞癌的治疗：化疗栓塞和肝移植后的病理结果
Transplant Proc. 1999 Feb-Mar;31(1-2):416-7. doi: 10.1016/s0041-1345(98)01686-8.
10
Hepatocellular carcinoma: gardening strategies and bridges to transplantation.肝细胞癌：治疗策略与肝移植桥梁
Liver Transpl. 2003 Feb;9(2):199-200. doi: 10.1053/jlts.2003.0090199.

引用本文的文献

1
Predicting waitlist dropout in hepatocellular carcinoma: a narrative review.预测肝细胞癌患者在等待名单上的退出情况：一项叙述性综述。
Transl Gastroenterol Hepatol. 2024 Aug 21;9:72. doi: 10.21037/tgh-24-24. eCollection 2024.
2
Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance.超声检查早期肝癌时的盲区的影响。
PLoS One. 2022 Sep 16;17(9):e0274747. doi: 10.1371/journal.pone.0274747. eCollection 2022.
3
Growth inhibition and apoptosis induced by 6-fluoro-3-formylchromone in hepatocellular carcinoma.
6-氟-3-甲酰基色酮诱导肝癌细胞生长抑制和凋亡
BMC Gastroenterol. 2014 Apr 3;14:62. doi: 10.1186/1471-230X-14-62.
4
Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma.索拉非尼在肝细胞癌治疗中作用的批判性评估。
Hepat Med. 2010 Nov 2;2:147-55. doi: 10.2147/HMER.S7123.
5
Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations.利用定量分析糖蛋白及其糖基化的综合平台鉴定和确认生物标志物。
J Proteome Res. 2010 Feb 5;9(2):798-805. doi: 10.1021/pr900715p.